- Staat
- DC
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 22.02.2023
- Impfdatum
- 27.10.2022
- Beginn
- 09.11.2022
- Tage bis Beginn
- 13,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Participant death 11/09/22
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Type 2 DM Hypertension Chronic Kidney Disease Morbid Obesity GERD
- Andere Medikamente
- Gabapentin Ozempic Metformin Lisinopril
- Allergien
- Penicillin Oxycodone
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 19.09.2022
- Impfdatum
- 18.09.2022
- Beginn
- 18.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Nausea
Syncope
Vomiting
Symptomtext
Vasovagal syncope with nausea and vomiting. Resolved with time. Parents present and took daughter home once stable and feeling fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- F
- Eingang
- 19.10.2023
- Impfdatum
- 03.12.2022
- Beginn
- 03.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Paraesthesia
Pharyngeal hypoaesthesia
Product after taste
Symptomtext
Right side of face and throat went numb, felt as if I could taste the vaccine as it was being administered; Tingling feeling in face; This non-serious case was reported by a consumer and described the occurrence of numbness facial in a 54-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) (batch number 9XL7N) for prophylaxis. Previously administered products included Flu vaccine (received every year). On 03-DEC-2022, the patient received Fluarix Quadrivalent 2022-2023 season (intramuscular) .5 ml. On 03-DEC-2022, less than a day after receiving Fluarix Quadrivalent 2022-2023 season, the patient experienced numbness facial (Verbatim: Right side of face and throat went numb, felt as if I could taste the vaccine as it was being administered) and tingling sensation (Verbatim: Tingling feeling in face). The outcome of the numbness facial and tingling sensation were resolved with sequelae. It was unknown if the reporter considered the numbness facial and tingling sensation to be related to Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device. It was unknown if the company considered the numbness facial and tingling sensation to be related to Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 10-OCT-2023 This report was submitted via the online direct entry reporting system. The patient stated that reaction to this vaccine was almost immediate. The administering physician took my vitals and entered reaction information into their computer system, but why this happened was never resolved. The patient still had slight numbness or tingling feeling on lower right side of my face or lip. The patient had received flu vaccines every year since 2006 and this reaction had never happened to her before until this past year after receiving flu vaccine. Right side of face and throat went numb, felt as if she could taste the vaccine as it was being administered. The symptoms were not treated. The reporter agreed to follow up with GlaxoSmithKline (GSK).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 05.06.2023
- Impfdatum
- 16.10.2022
- Beginn
- 26.05.2023
- Tage bis Beginn
- 222,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Cough
Dyspnoea exertional
Headache
Oropharyngeal pain
Respiratory tract congestion
SARS-CoV-2 test positive
Symptomtext
I had a sore throat, headache, congestion, coughing, diffuculty breathing upon exerttion only.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea exertional
- Hospital-Tage
- -
- Labordaten
- 27MAY2023 COVID-19 Test-Positive.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Doxycycline; Levothyroxine; Metronidazole; Vitamin B12; Iron; Calcium
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 08.11.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cough
Dyspnoea
Erythema
Rash
Throat irritation
Wheezing
Symptomtext
about an hour after vaccination patient began experiencing coughing/wheezing, SOB, throat irritation. woke up next morning with redness and rash to arms, stomach and back. patient took a total of 50 mg Benadryl which relieved symptoms. Symptoms lasted about 2 weeks. Patient has experienced symptoms in the past but not as bad. Patient is not allergic to eggs or any other immunizations that she is aware of.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 9,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash erythematous
Symptomtext
Immunizations were given at 1607, at 1615 a red rash was noticed around pt's eyes and also forehead and cheeks. Also noticed red rash to arms bilat. Pt denied that he was short of breath or that his throat itched. Pt was also afebrile. Checked pt's 02 saturation and level was at 88% on room air. Brought pt and guardian over to the clinic to be evaluated by a provider. Pt was brought back to clinic room by clinic staff to be triaged and evaluated. Pt was placed on 2L of 02 per nasal cannula by clinic nurse and sats then when up to 93%.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Influenza A 12/18/2022
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Ceftriaxone, Rocephin
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 23.11.2022
- Impfdatum
- 21.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Immediate post-injection reaction
Pain
Pain in extremity
Symptomtext
patient said shot caused immediate pain, radiating down arm. hasn't gotten better. got medical atttention to noted to get a MRI
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 12.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site swelling
Symptomtext
pain at the injection site; swelling at the injection site; This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 64-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) (batch number 9XL7N, expiry date 30th June 2023) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 31st October 2022, the patient received Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, less than a week after receiving Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced injection site pain and injection site swelling. On an unknown date, the outcome of the injection site pain and injection site swelling were not recovered/not resolved. It was unknown if the reporter considered the injection site pain and injection site swelling to be related to Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-Nov-2022 Reporter's comment: The patient received dose of Fluarix vaccine and experienced pain and swelling at the injection site. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 12.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Pain
Skin discolouration
Swelling
Symptomtext
Red; Silver dollar size bump; Silver dollar size bump; Painful; This case was reported by a nurse via sales rep and described the occurrence of erythema in a 64-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) (batch number 9XL7N, expiry date 30th June 2023) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 31st October 2022, the patient received Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, less than a week after receiving Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced erythema, skin discoloration, local swelling and pain. On an unknown date, the outcome of the erythema, skin discoloration, local swelling and pain were unknown. It was unknown if the reporter considered the erythema, skin discoloration, local swelling and pain to be related to Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-NOV-2022 Reporter's Comment: The reporter was a nurse. The reporter reported that the patient was a retired nurse. The reporter stated that the patient received Fluarix vaccine and after that she experienced red, painful and silver dollar size bump. The reporter agrees to follow up from GlaxoSmithKline.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 07.10.2022
- Beginn
- 13.10.2022
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema multiforme
Rash
Symptomtext
Patient developed erythema multiforme rash beginning on 10/13/2022 (6 days after immunizations given). Called office and initially advised that full body rash would be consistent with reaction to MMR vaccine. However, later sent pictures consistent with EM. Rash continued to progress peaking on 10/19 and beginning to resolve 10/20/2022. Patient did not take any medications at any time, did not have any fever or other signs of illness. Had not recently taken any medications prescribed or over the counter. No tylenol, motrin, etc. Only can be attributed to immunizations and would assume that this would be due to MMR vaccine due to the delay in reaction.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- PDA and pulmonary valve stenosis - resolved exotropia
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 24.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 23.10.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Headache
Pain
Spinal pain
Symptomtext
Client's grandmother called to report. She states since yesterday morning 10/23/2022 whenever the client stands up he gets a shooting pain from back of his head, to his eyes, down his spine. They have been monitoring it since yesterday morning and it's been consistent for over 24 hours. Client took Tylenol which has not improved this shooting pain. Writer advised to get patient seen by physician as soon as possible to find root cause.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- melatonin, tylenol
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 21.10.2022
- Impfdatum
- 23.09.2022
- Beginn
- 23.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Immediate post-injection reaction
Injection site pain
Neck pain
Pain
Pain in extremity
Vaccination site pain
X-ray normal
Symptomtext
Noted immediately with vaccine there was pain that shot up through shoulder and to neck. Also had pain in shoulder area radiating down same arm which began same day. Neck, shoulder, and arm pain continues daily, area of vaccine still burns and stings even today. Arm is also easily fatigued and pain/discomfort is worse at night. She experienced numbness down left leg for 2 nights after vaccine but this has since gone away. Patient went to orthopedic doctor who did xrays with no significant findings. No treatment was ordered. Patient follows up with him Oct 28, 2022.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- x-rays done at Clinic on 10/14/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 21.10.2022
- Impfdatum
- 30.09.2022
- Beginn
- 30.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Irritability
Off label use
Overdose
Product preparation error
Product preparation issue
Product use issue
Vaccination site pain
Symptomtext
The child received 10 doses.; administered the full vial, undiluted; Off label use; Product use for unapproved combination; had soreness at her right arm injection site; a little fatigued and cranky; a little fatigued and cranky; This is a spontaneous report received from contactable reporter(s) (Other HCP) from medical information team. A 3-year-old female patient received BNT162b2 (BNT162B2), on 30Sep2022 at 11:00 as dose 2 (maroon cap), single (Lot number: FT9142, Expiration Date: 01Nov2022) at the age of 3 years, in left arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), on 30Sep2022 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: BNT162b2 (DOSE 1 (MAROON CAP), SINGLE, NCD: 59267-0078-1, lot: FT9142, Pfizer), administration date: 01Sep2022, when the patient was 3-year-old, for Covid-19 Immunization. The following information was reported: IRRITABILITY (non-serious), FATIGUE (non-serious) all with onset 30Sep2022, outcome "recovered" (02Oct2022) and all described as "a little fatigued and cranky"; VACCINATION SITE PAIN (non-serious) with onset 30Sep2022, outcome "recovered" (02Oct2022), described as "had soreness at her right arm injection site"; OFF LABEL USE (non-serious) with onset 30Sep2022 at 11:00, outcome "unknown"; PRODUCT USE ISSUE (non-serious) with onset 30Sep2022 at 11:00, outcome "unknown", described as "Product use for unapproved combination"; OVERDOSE (non-serious) with onset 30Sep2022 at 11:00, outcome "unknown", described as "The child received 10 doses."; PRODUCT PREPARATION ERROR (non-serious) with onset 30Sep2022 at 11:00, outcome "unknown", described as "administered the full vial, undiluted". Additional Information: Warm transfer from (name) Pfizer Medical Information INT-#. Reporting an incident with one of their patients. It was a 3-year-old girl patient. She has received the COVID vaccine from Pfizer -maroon cap. The nurse administered the full vial, undiluted. The child received 10 doses. The child is fine. The caller confirmed the details provided by the transferring agent. This happened during the immunizations clinic.This occurred about 11 am this morning 30Sep2022. Seriousness: it is serious to have a med error like this, but the baby is fine. She was fine during the 15-minute observation. It is not disabling at this time. They are expecting an increased systemic response. She also received the flu shot today. This was her second dose of the COVID vaccine. She didn't have any medications listed on her consent form .Patient's Medical History (including any illness at time of vaccination): Provide other relevant medical history including but not limited to these conditions: diagnosed allergies, compromised immune status, respiratory illness, genetic/chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity: no. Relevant Tests: List other relevant diagnostic and confirmatory test results for event(s), for example, from blood tests, cerebrospinal fluid culture, bacterial sero-type, diagnostic imaging, (e.g., chest X-ray, MRI): no. Caller is an Manager with (city name) (state name) health department. One of her nurses administered 1 full vial of undiluted Pfizer BioNtech Covid vaccine maroon cap to a 3yo girl. Child waited customary 15min post vaccine dose and was fine. Error was noticed later when they were counting the doses. Child received 10 doses of the undiluted product. Event occurred today. Wants to know the procedure to follow post administration. On 03Oct2022, according to the call recording, the reporter stated that a 3-year-old female patient was administered the contents of a full undiluted vial, which contains 10 doses; so, 1 child received 10 doses. Upon follow up on 17Oct2022, it was reported that the phone out 3:15pm. Phone answered by reporter who provided an update. She spoke to the parents who said the patient had soreness at her right arm injection site and was a little fatigued and cranky that Friday. By Sunday she was back to her normal self and running around playing and was fine now. Follow-up (03Oct2022): This is a spontaneous follow-up report received in response to the mail trail sent confirming that 1 child received 10 doses. Updated information includes: additional clinical details. Follow-up attempts are completed. No further information is expected. Follow-up (17Oct2022): This is a spontaneous follow-up report from a contactable Other HCP. This Other HCP reported in response to HCP letter sent via telephonic follow-up activity. Updated information included: New events (Product use for unapproved combination, Off label use vaccination site pain, irritability, and fatigue) and Additional information added. Follow-up attempts are completed. No further information is expected.; Sender's Comments: The event of Overdose is assessed as related to suspect drug BNT162b2
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 03.10.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Joint range of motion decreased
Product administered at inappropriate site
Symptomtext
Vaccine administered into subacromial/subdeltoid space causing significant pain and limited range of motion of the left shoulder joint. This has persisted for several weeks with worsening pain over time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 23.09.2022
- Impfdatum
- 20.09.2022
- Beginn
- 22.09.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pain
Pyrexia
Wrong product administered
Symptomtext
Client administered Fluarix in error. Client had registered for Tdap/Boostrix vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- None. Client reported fever and aches on 9/22 in interview with PHN. PHN reviewed VIS with client. Client reports past medical history with possible diagnosis of Guillain Barre illness. Client referred to a clinic same day appointment line to review symptoms. Unknown at this time if client proceeded to make a visit/televisit to other healthcare office or receive any other treatment.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Lymes disease
- Andere Medikamente
- unknown
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 26.10.2023
- Impfdatum
- 16.10.2023
- Beginn
- 16.10.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
they inadvertently administered an expired Fluarix (exp:6/30/23) vaccine this morning on 10/16/23 to a patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 42-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) (batch number 9XL7N, expiry date 30-JUN-2023) for prophylaxis. On 16-OCT-2023, the patient received Fluarix Quadrivalent 2022-2023 season (right deltoid). On 16-OCT-2023, an unknown time after receiving Fluarix Quadrivalent 2022-2023 season, the patient experienced expired vaccine used (Verbatim: they inadvertently administered an expired Fluarix (exp:6/30/23) vaccine this morning on 10/16/23 to a patient). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-OCT-2023 The reporter was medical assistant. The reporter called to inquire that how to proceed and would the patient need to be revaccinated. The reporter reported that they inadvertently administered an expired Fluarix vaccine this morning to a patient in the right deltoid, which led to expired vaccine used. The reporter did not consent to follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 19.12.2022
- Impfdatum
- 30.11.2022
- Beginn
- 30.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Feeling hot
Immediate post-injection reaction
Posture abnormal
Staring
Unresponsive to stimuli
Symptomtext
Patient was to receive HPV, Flu, Menningitis & TDAP. He was given HPV & Menningitis in Lt Deltoid then flu in Rt Deltoid. Immediately after 3rd injection he had blank stare, became unresponsive & went limp into Mothers arms as she was standing behind him. I called for help & as Dr. and PA came into room patient was coming to. Vitals were taken and were within acceptable limits. Patient complained of being hot so I placed fan in room which he stated helped. Within 10 minutes patient's color had improved, he was talking and responding appropriately. He remained in room sitting in chair talking & laughing with mother & sister as she was waiting her post vaccine shot time. Patient was then discharged in care of mother with normal vital signs and no appearnt distress.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Feeling hot
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 02.12.2022
- Impfdatum
- 02.12.2022
- Beginn
- 02.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
No adverse event
Symptomtext
Patients shot record had stated she need a second dose of her Influenza as of 10/25/22. Therefore we gave her a dose of Influenza on 12/02/2022. When entering the vaccine it was charted that she received a dose of Influenza on 11/29/2022, but it was not reflected on her record. This meaning the patient had received a third dose of Influenza. Doctor was notified and ensured that the extra dose would not harm her. As of the patient leaving our office she had no medically adverse reactions, she had just received an extra dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 01.12.2022
- Impfdatum
- 23.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Gave flu Vaccine dose from children's stock to a 19 year old.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 16.11.2022
- Impfdatum
- 16.11.2022
- Beginn
- 16.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
Patient received covid booster when she should have received a flu shot. Patient presented covid card at the time of vaccination and told vaccinator after that she was here for the flu shot
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 68,0
- Geschlecht
- M
- Eingang
- 12.11.2022
- Impfdatum
- 02.11.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Got a dose 19OCT2022 and another 2NOV2022; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 68-year-old male patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) (batch number 9XL7N, expiry date 30th June 2023) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. Concomitant products included INFLUENZA VACCINE INACT SPLIT 4V (FLUARIX QUADRIVALENT). On 2nd November 2022, the patient received Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device. On 2nd November 2022, unknown after receiving Fluarix Quadrivalent 2022-2023 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 2-Nov-2022 Reporter's comment: The caller provided an email after transfer to second-line agent. The caller did not ask if email follow-up was okay because the health care professional wanted to remain anonymous in their system. In accordance with their ways of working, the caller will email the health care professional's contact details. The caller consented to follow-up with a phone call, but the caller wished to stay anonymous in their system. Additional supportive information: The patient inadvertently received another dose of Fluarix (same lot) on the day of reporting, which led to extra dose administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 08.11.2022
- Impfdatum
- 10.09.2022
- Beginn
- 10.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect product formulation administered
Wrong product administered
Symptomtext
I was supposed to receive the Moderna Bivalent booster, but was given the Pfizer original formulation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 02.11.2022
- Impfdatum
- 28.10.2022
- Beginn
- 28.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Incorrect dose administered
Symptomtext
5-11yr vaccine was diluted prior to admin. In doing so, patient was given 20mcg booster dose instead of the appropriate 10mcg dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 12.10.2022
- Impfdatum
- 06.10.2022
- Beginn
- 06.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Wrong product administered
Symptomtext
This client requested just the COVID19 vaccine but was given Fluarix Quad. Client notified of the mistake and still wanted the COVID19 vaccine so received both vaccines the same day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 11.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
No adverse event
Symptomtext
No known adverse event. No known bad outcomes as of the date of this report. Vaccine administration error. Patient was intended to receive Moderna "bivalent" 0.5 mL booster dose; received Moderna "monovalent" 0.5 mL dose in error. Vaccinating nurse did not readily distinguish between the similarly colored Moderna monovalent vial and the bivalent vial. Did not notice the lack of "bivalent" labeling/grey colored strip on front of monovalent vial/purple strip on front of vial. Both vials have same blue cap.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- Factor V Leiden Mutation
- Andere Medikamente
- none known
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 11.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Symptomtext
No known adverse event. No known bad outcomes as of the date of this report. Vaccine administration error. Patient was intended to receive Moderna "bivalent" 0.5 mL booster dose; received Moderna "monovalent" 0.5 mL dose in error. Vaccinating nurse did not readily distinguish between the similarly colored Moderna monovalent vial and the bivalent vial. Did not notice the lack of "bivalent" labeling/grey colored strip on front of monovalent vial/purple strip on front of vial. Both vials have same blue cap.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- none.
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- none known
- Andere Medikamente
- none known
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 11.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
No known adverse event. No known bad outcomes as of the date of this report. Vaccine administration error. Patient was intended to receive Moderna "bivalent" 0.5 mL booster dose; received Moderna "monovalent" 0.5 mL dose in error. Vaccinating nurse did not readily distinguish between the similarly colored Moderna monovalent vial and the bivalent vial. Did not notice the lack of "bivalent" labeling/grey colored strip on front of monovalent vial/purple strip on front of vial. Both vials have same blue cap.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- none.
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- arthritis
- Andere Medikamente
- none known
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 0,2
- Geschlecht
- F
- Eingang
- 05.10.2022
- Impfdatum
- 27.09.2022
- Beginn
- 27.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
2 month old pt was administered Fluarix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2022-2023 season) (batch number 9XL7N, expiry date 30th June 2023) for prophylaxis. On 27th September 2022, the patient received Fluarix Quadrivalent 2022-2023 season. On 27th September 2022, unknown after receiving Fluarix Quadrivalent 2022-2023 season, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional Information: GSK receipt date: 27-Sept-2022 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter gave permission for follow-up but declined to provide her last name. Additional supportive information: The patient received Fluarix QIV at inappropriate age, which led to inappropriate age at vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 13.09.2022
- Impfdatum
- 10.09.2022
- Beginn
- 10.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Original pfizer was given instead of bivalent. CDC recommended no course of action needed may receive bivalent in 2 months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 13.09.2022
- Impfdatum
- 10.09.2022
- Beginn
- 10.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Wrong product administered
Symptomtext
Original pfizer was given instead of bivalent. CDC recommended no course of action needed may receive bivalent in 2 months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 12.09.2022
- Impfdatum
- 10.09.2022
- Beginn
- 10.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
Symptomtext
Patient received original pfizer formulation instead of bivalent. CDC recommended no action may receive bivalent in 2 months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -